Chlorine in PDB 6io0: Human IDH1 R132C Mutant Complexed with Compound A.
Enzymatic activity of Human IDH1 R132C Mutant Complexed with Compound A.
All present enzymatic activity of Human IDH1 R132C Mutant Complexed with Compound A.:
1.1.1.42;
Protein crystallography data
The structure of Human IDH1 R132C Mutant Complexed with Compound A., PDB code: 6io0
was solved by
M.Suzuki,
D.Baba,
H.Hanzawa,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
25.00 /
2.20
|
Space group
|
P 43 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
82.750,
82.750,
296.420,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19 /
25.5
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Human IDH1 R132C Mutant Complexed with Compound A.
(pdb code 6io0). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Human IDH1 R132C Mutant Complexed with Compound A., PDB code: 6io0:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 6io0
Go back to
Chlorine Binding Sites List in 6io0
Chlorine binding site 1 out
of 4 in the Human IDH1 R132C Mutant Complexed with Compound A.
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Human IDH1 R132C Mutant Complexed with Compound A. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl501
b:49.3
occ:1.00
|
CL1
|
A:AOU501
|
0.0
|
49.3
|
1.0
|
C15
|
A:AOU501
|
1.7
|
47.9
|
1.0
|
C10
|
A:AOU501
|
2.7
|
48.1
|
1.0
|
C6
|
A:AOU501
|
2.7
|
49.6
|
1.0
|
C34
|
A:AOU501
|
3.1
|
49.0
|
1.0
|
N2
|
A:AOU501
|
3.3
|
48.9
|
1.0
|
CZ3
|
A:TRP267
|
3.7
|
36.2
|
1.0
|
C8
|
A:AOU501
|
3.7
|
46.2
|
1.0
|
CE
|
A:MET259
|
3.8
|
43.8
|
1.0
|
CZ2
|
A:TRP124
|
3.9
|
44.4
|
1.0
|
CH2
|
A:TRP267
|
4.0
|
34.4
|
1.0
|
CB
|
A:ALA258
|
4.0
|
38.6
|
1.0
|
C14
|
A:AOU501
|
4.0
|
51.6
|
1.0
|
C2
|
A:AOU501
|
4.1
|
52.8
|
1.0
|
C35
|
A:AOU501
|
4.1
|
51.7
|
1.0
|
CH2
|
A:TRP124
|
4.1
|
46.6
|
1.0
|
O29
|
A:AOU501
|
4.4
|
50.4
|
1.0
|
N1
|
A:AOU501
|
4.4
|
49.6
|
1.0
|
C33
|
A:AOU501
|
4.5
|
45.0
|
1.0
|
C5
|
A:AOU501
|
4.6
|
54.5
|
1.0
|
C1
|
A:AOU501
|
4.6
|
52.3
|
1.0
|
SD
|
A:MET259
|
4.7
|
53.8
|
1.0
|
C36
|
A:AOU501
|
4.7
|
55.5
|
1.0
|
CG1
|
A:VAL255
|
4.7
|
34.1
|
1.0
|
O
|
A:VAL255
|
4.8
|
38.7
|
1.0
|
C20
|
A:AOU501
|
4.9
|
55.1
|
1.0
|
CE3
|
A:TRP267
|
4.9
|
35.8
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 6io0
Go back to
Chlorine Binding Sites List in 6io0
Chlorine binding site 2 out
of 4 in the Human IDH1 R132C Mutant Complexed with Compound A.
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Human IDH1 R132C Mutant Complexed with Compound A. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl501
b:52.9
occ:1.00
|
CL2
|
A:AOU501
|
0.0
|
52.9
|
1.0
|
C14
|
A:AOU501
|
1.7
|
51.6
|
1.0
|
C10
|
A:AOU501
|
2.7
|
48.1
|
1.0
|
C5
|
A:AOU501
|
2.7
|
54.5
|
1.0
|
C34
|
A:AOU501
|
2.9
|
49.0
|
1.0
|
C35
|
A:AOU501
|
3.3
|
51.7
|
1.0
|
C20
|
A:AOU501
|
3.4
|
55.1
|
1.0
|
O27
|
A:AOU501
|
3.5
|
58.6
|
1.0
|
CG2
|
A:VAL281
|
3.7
|
58.4
|
1.0
|
N2
|
A:AOU501
|
3.7
|
48.9
|
1.0
|
CB
|
B:GLN277
|
3.9
|
84.9
|
1.0
|
C15
|
A:AOU501
|
4.0
|
47.9
|
1.0
|
C2
|
A:AOU501
|
4.0
|
52.8
|
1.0
|
CG2
|
B:VAL281
|
4.1
|
35.4
|
1.0
|
C36
|
A:AOU501
|
4.2
|
55.5
|
1.0
|
C1
|
A:AOU501
|
4.2
|
52.3
|
1.0
|
O29
|
A:AOU501
|
4.4
|
50.4
|
1.0
|
C6
|
A:AOU501
|
4.5
|
49.6
|
1.0
|
CB
|
B:SER280
|
4.6
|
48.0
|
1.0
|
O
|
B:GLN277
|
4.6
|
69.3
|
1.0
|
CB
|
A:VAL281
|
4.8
|
70.5
|
1.0
|
C13
|
A:AOU501
|
4.9
|
53.2
|
1.0
|
CG1
|
A:VAL281
|
4.9
|
63.4
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 6io0
Go back to
Chlorine Binding Sites List in 6io0
Chlorine binding site 3 out
of 4 in the Human IDH1 R132C Mutant Complexed with Compound A.
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Human IDH1 R132C Mutant Complexed with Compound A. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl506
b:48.1
occ:1.00
|
CL1
|
B:AOU506
|
0.0
|
48.1
|
1.0
|
C15
|
B:AOU506
|
1.7
|
44.0
|
1.0
|
C6
|
B:AOU506
|
2.7
|
40.9
|
1.0
|
C10
|
B:AOU506
|
2.7
|
39.8
|
1.0
|
C34
|
B:AOU506
|
3.1
|
40.3
|
1.0
|
CE
|
B:MET259
|
3.1
|
98.9
|
1.0
|
N2
|
B:AOU506
|
3.3
|
45.9
|
1.0
|
C8
|
B:AOU506
|
3.8
|
39.3
|
1.0
|
CZ3
|
B:TRP267
|
3.8
|
32.9
|
1.0
|
CZ2
|
B:TRP124
|
4.0
|
40.3
|
1.0
|
C2
|
B:AOU506
|
4.0
|
43.3
|
1.0
|
C14
|
B:AOU506
|
4.0
|
43.1
|
1.0
|
CB
|
B:ALA258
|
4.1
|
43.5
|
1.0
|
CH2
|
B:TRP124
|
4.1
|
40.3
|
1.0
|
C35
|
B:AOU506
|
4.1
|
42.2
|
1.0
|
CH2
|
B:TRP267
|
4.2
|
33.8
|
1.0
|
O29
|
B:AOU506
|
4.3
|
47.8
|
1.0
|
N1
|
B:AOU506
|
4.4
|
41.5
|
1.0
|
C33
|
B:AOU506
|
4.5
|
36.8
|
1.0
|
O
|
B:VAL255
|
4.5
|
43.4
|
1.0
|
C1
|
B:AOU506
|
4.6
|
43.1
|
1.0
|
C5
|
B:AOU506
|
4.6
|
39.5
|
1.0
|
CG1
|
B:VAL255
|
4.7
|
42.1
|
1.0
|
C36
|
B:AOU506
|
4.7
|
46.7
|
1.0
|
CA
|
B:VAL255
|
4.8
|
44.1
|
1.0
|
SD
|
B:MET259
|
4.8
|
83.9
|
1.0
|
C20
|
B:AOU506
|
4.9
|
43.4
|
1.0
|
N
|
B:MET259
|
5.0
|
48.4
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 6io0
Go back to
Chlorine Binding Sites List in 6io0
Chlorine binding site 4 out
of 4 in the Human IDH1 R132C Mutant Complexed with Compound A.
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Human IDH1 R132C Mutant Complexed with Compound A. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl506
b:45.9
occ:1.00
|
CL2
|
B:AOU506
|
0.0
|
45.9
|
1.0
|
C14
|
B:AOU506
|
1.7
|
43.1
|
1.0
|
C5
|
B:AOU506
|
2.6
|
39.5
|
1.0
|
C10
|
B:AOU506
|
2.7
|
39.8
|
1.0
|
C34
|
B:AOU506
|
3.0
|
40.3
|
1.0
|
C35
|
B:AOU506
|
3.3
|
42.2
|
1.0
|
O27
|
B:AOU506
|
3.4
|
48.1
|
1.0
|
C20
|
B:AOU506
|
3.4
|
43.4
|
1.0
|
CG2
|
A:VAL281
|
3.6
|
58.4
|
1.0
|
CA
|
A:VAL281
|
3.7
|
74.6
|
1.0
|
CG2
|
B:VAL281
|
3.8
|
35.4
|
1.0
|
N2
|
B:AOU506
|
3.9
|
45.9
|
1.0
|
C2
|
B:AOU506
|
3.9
|
43.3
|
1.0
|
C15
|
B:AOU506
|
4.0
|
44.0
|
1.0
|
CB
|
A:VAL281
|
4.1
|
70.5
|
1.0
|
N
|
A:VAL281
|
4.2
|
79.2
|
1.0
|
C1
|
B:AOU506
|
4.2
|
43.1
|
1.0
|
CG1
|
B:VAL281
|
4.3
|
32.2
|
1.0
|
O
|
A:SER280
|
4.3
|
71.3
|
1.0
|
C36
|
B:AOU506
|
4.3
|
46.7
|
1.0
|
C
|
A:SER280
|
4.4
|
79.5
|
1.0
|
C6
|
B:AOU506
|
4.5
|
40.9
|
1.0
|
CG1
|
A:VAL281
|
4.5
|
63.4
|
1.0
|
CB
|
B:VAL281
|
4.6
|
36.0
|
1.0
|
O29
|
B:AOU506
|
4.6
|
47.8
|
1.0
|
O
|
A:VAL281
|
4.7
|
75.5
|
1.0
|
C
|
A:VAL281
|
4.8
|
80.6
|
1.0
|
C13
|
B:AOU506
|
4.8
|
42.5
|
1.0
|
O
|
A:HOH711
|
4.9
|
56.5
|
1.0
|
C4
|
B:AOU506
|
4.9
|
39.8
|
1.0
|
|
Reference:
Y.Machida,
M.Nakagawa,
H.Matsunaga,
M.Yamaguchi,
Y.Ogawara,
Y.Shima,
K.Yamagata,
T.Katsumoto,
A.Hattori,
M.Itoh,
T.Seki,
Y.Nishiya,
K.Nakamura,
K.Suzuki,
T.Imaoka,
D.Baba,
M.Suzuki,
O.Sampetrean,
H.Saya,
K.Ichimura,
I.Kitabayashi.
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in A Patient-Derived Orthotopic Xenograft Model. Mol.Cancer Ther. 2019.
ISSN: ESSN 1538-8514
PubMed: 31727689
DOI: 10.1158/1535-7163.MCT-18-1349
Page generated: Sun Jul 28 01:47:02 2024
|